Press Release February 16, 2023 Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 Read More
February 16, 2023 Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 Read More
